How many drugs treat Periodontitis Adjunct Therapy?

Drug Landscape tracks 2 marketed treatments for Periodontitis Adjunct Therapy (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/periodontitis-adjunct-therapy.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Periodontitis Adjunct Therapy — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Periodontitis Adjunct Therapy (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Periodontitis Adjunct Therapy, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Vibramycin	doxycycline	Generic (originally Pfizer)	Tetracycline antibiotic	72 kDa type IV collagenase, Stromelysin-1, Collagenase 3		1967-01-01
Doxycyclin	Doxycyclin	Bulovka Hospital		72 kDa type IV collagenase, Stromelysin-1, Collagenase 3

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Bulovka Hospital · 1 drug in Periodontitis Adjunct Therapy
Generic (originally Pfizer) · 1 drug in Periodontitis Adjunct Therapy

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Periodontitis Adjunct Therapy:

Cite this brief

Drug Landscape (2026). Periodontitis Adjunct Therapy — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/periodontitis-adjunct-therapy. Accessed 2026-06-10.

Periodontitis Adjunct Therapy full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing